Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 37.66% vs 26.89% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 109.34% vs 42.35% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 18.43% vs 41.26% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 286.10% vs 68.94% in Mar 2024
Compare Profit and Loss Results of Neochem Bio
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
84.00
229.00
-145.00
-63.32%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
84.00
229.00
-145.00
-63.32%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-11.00
11.00
100.00%
Raw Materials Consumed
55.00
166.00
-111.00
-66.87%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
8.00
19.00
-11.00
-57.89%
Operating Expenses
1.00
10.00
-9.00
-90.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
6.00
-5.00
-83.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
71.00
207.00
-136.00
-65.70%
Operating Profit (PBDIT) excl Other Income
12.00
22.00
-10.00
-45.45%
Other Income
1.00
3.00
-2.00
-66.67%
Operating Profit (PBDIT)
14.00
26.00
-12.00
-46.15%
Interest
3.00
1.00
2.00
200.00%
Profit before Depriciation and Tax
11.00
24.00
-13.00
-54.17%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
9.00
21.00
-12.00
-57.14%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
21.00
-12.00
-57.14%
Provision for Tax
2.00
5.00
-3.00
-60.00%
Profit After Tax
7.00
15.00
-8.00
-53.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
94.00
-90.00
-95.74%
Profit Available for appropriations
11.00
110.00
-99.00
-90.00%
Appropriations
11.00
110.00
-99.00
-90.00%
Equity Dividend (%)
0%
5%
-5.00
Earnings Per Share
11.15
1.18
9.97
844.92%
Profit And Loss - Net Sales
Net Sales 84.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.66% vs 26.89% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 109.34% vs 42.35% in Mar 2024
Profit And Loss - Interest
Interest 3.51 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.43% vs 41.26% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 7.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 286.10% vs 68.94% in Mar 2024






